From the gallery

Original image available on AdPharm.net – (2542 x 1800 pixels)

Join the MyBoniva Program and get one month of Boniva free!
I wanted to stop my cone loss. But I did more. I reversed it with Boniva.
MyBoniva is a free program that delivers ideas and support that can help women manage their osteoporosis.

You’ll get:

• One month of Boniva free
• Helpful monthly reminders to take your Boniva delivered by phone, e-mail, or mail
• Updates from Sally Field
• Quarterly newsletters filled with valuable information.

Did you know osteoporosis runs in families? My mother and I both have it. I tried to keep my bones strong, but it wasn’t enough. Now once-monthly Boniva is helping to do more. Studies show, after a year on Boniva, 9 out of 10 women stopped and reversed their bone loss.

Boniva is a prescription medication to treat and prevent postmenopausal osteoporosis.

Ask your doctor if Boniva is right for you.

Enroll today. Call 1-800-240-5977 or visit Bonivafreetrial.com and try Boniva free.

Brand name: Boniva
Generic name/category: ibandronate sodium
Company: Genentech and GlaxoSmithKline
Country/Market: USA, North America
Indication(s)/use: help stop and reverse bone loss in osteoporosis
Target: Consumers (DTC)
Tagline: Help stop and reverse bone loss
Medium: Print ad
Size/duration: One and a half page
Publication/Aired: Prevention – March 2010

To see all of this brand’s ads on AdPharm, click here

Click here to see all Boniva ads on AdPharm

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

Happy Holidays

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Tough as ever, but a bit more refined

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Description: A man talks on-screen about the dangers of high cholesterol that may cause plaque buildup. He then invites viewers to visit Arterytour.com to get additional information via their interactive online tour. Arterytour.com is a comprehensive sales-pitch site for Crestor. Whats new about this site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.

Click here to visit the site.

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Learn about high cholesterol and plaque buildup. Take an interactive artery tour.

Description: This is a very elaborate site on the risks associated with high cholesterol and plaque buildup. It also is a comprehensive sales-pitch for Crestor. Whats new about this Crestor site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.

Click here to visit the site.

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Internet
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Description: People from different walks of life talk about cholesterol and how much they thought they knew about it and in reality they don’t. A spokesperson then comes in and talks about the risks associated with high cholesterol and its link with plaque buildup using animated visuals…

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the details and full-size versions of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.